Over at evolgen, the blogger who goes by RPM links to a video interview with Michael Ashburner hosted by BioMed Central. In the interview, Ashburner is "espousing the virtues of open access," writes RPM, noting that the highly regarded scientist "also walks the walk, proclaiming that he will not publish in non-open access journal, nor review articles for non-open access journals."

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.